Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
15°
Site search
Search
Menu
Subscribe
Home
News
Local News
Sports
Obituaries
e-Edition
Classifieds
Real Estate
Property For Rent
Cars & Vehicles
Jobs
Items For Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place An Ad
Explore the Sheyenne
Archives
Best of 2024
Calendar Photos
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Atai Life Sciences N.V.
(NQ:
ATAI
)
1.520
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EST, Nov 21, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Atai Life Sciences N.V.
< Previous
1
2
3
4
5
6
7
8
9
...
26
27
Next >
Seelos Therapeutics, ATAI Life Sciences Among Top Psychedelic Movers Of Today
March 14, 2023
Via
Benzinga
Stocks That Hit 52-Week Lows On Tuesday
March 14, 2023
Tuesday's morning session saw 84 companies set new 52-week lows.
Via
Benzinga
The Latest Analyst Ratings for ATAI Life Sciences
March 07, 2023
Via
Benzinga
Atai Layoffs 2023: What to Know About the Latest ATAI Job Cuts
March 06, 2023
Atai Life Sciences has just announced 30% job cuts. Here's how investors should be interpreting the Atai layoffs as ATAI stock rises.
Via
InvestorPlace
Atai Life Sciences: Long On Money; Short On Success
March 06, 2023
A review of Atai Life Sciences' latest quarterly financials, the history of its stock price performance, and the price forecasts for the stock over the next 12 months.
Via
Talk Markets
ATAI Life Sciences, Compass Pathways Among Top Psychedelic Movers Of Today
March 13, 2023
Via
Benzinga
Psyched: Next-Gen Compounds For Depression, Congress, Rescheduling, Benzinga Psychedelics Conference & More
March 13, 2023
Major Depressive Disorder: Small Pharma’s Phase 2 DMT Trial, BetterLife’s Preclinical LSD Trial
Via
Benzinga
Major Psychedelics VC & EFT Directors Will Share Valuable Insights At Upcoming Benzinga Event
March 13, 2023
The Benzinga Psychedelics Capital Conference (PCC) is rapidly becoming the place to be for all those interested or involved in the space. In addition to being the place where deals are done, you'll...
Via
Benzinga
Seelos Therapeutics, GH Research Among Top Psychedelic Movers Of Today
March 10, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 9, 2023
March 09, 2023
Via
Benzinga
Numinus Wellness, Seelos Therapeutics Among Top Psychedelic Movers Of Today
March 08, 2023
Via
Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
March 07, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 6, 2023
March 06, 2023
Via
Benzinga
Atai Update: Ketamine Trials Are Ongoing, Company Cuts 30% Workforce
March 06, 2023
The clinical-stage biopharma company atai Life Sciences (NASDAQ: ATAI) founded in 2018 shared updates on the two clinical trials as well as its plan to streamline its workforce with significant...
Via
Benzinga
Here Are The Year's Highest Priced Psychedelics Stocks In US Markets
March 06, 2023
After everything that's happened in the last several years, we believe it's safe to say that the psychedelic renaissance is a reality, one that Benzinga has consistently reported on.
Via
Benzinga
atai Life Sciences Announces Key Clinical Pipeline and Corporate Updates
March 06, 2023
From
atai Life Sciences
Via
GlobeNewswire
Cybin, GH Research Among Top Psychedelic Movers Of Today
March 03, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From March 2, 2023
March 02, 2023
Via
Benzinga
Cybin, GH Research Among Top Psychedelic Movers Of Today
March 01, 2023
Via
Benzinga
atai Life Sciences to Participate in the Cowen 43rd Annual Health Care Conference
March 01, 2023
From
atai Life Sciences
Via
GlobeNewswire
Psychedelic Stock Gainers And Losers From February 28, 2023
February 28, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 27, 2023
February 27, 2023
Via
Benzinga
"Rags-To-Riches" Portfolio Outpacing S&P 500 By 2-To-1 Margin
February 27, 2023
The
Via
Talk Markets
Of The 6 Largest Psychedelic Drug Stocks, Only One Has Not Advanced YTD
February 26, 2023
The most critical financial information on the health of a company is whether, or not, it has a Net Positive Operating Cash Flow; its Altman -Z Score; its Piotroski F-Score; and the percentage...
Via
Talk Markets
Psychedelic Stock Gainers And Losers From February 24, 2023
February 24, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 23, 2023
February 23, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 22, 2023
February 22, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 21, 2023
February 21, 2023
Via
Benzinga
Psychedelic Stock Gainers And Losers From February 20, 2023
February 20, 2023
Via
Benzinga
"Rags-To-Riches" Portfolio Underperforming YTD
February 19, 2023
The munKNEE
Via
Talk Markets
< Previous
1
2
3
4
5
6
7
8
9
...
26
27
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
